Peter Jackson

Formerly Vice President of Avecia’s Pharmaceutical Products business and CEO of Reaxa Ltd which was sold to Johnson Matthey. Peter is also co-founder and Non-Executive Director of Redx Pharma and founder of ADC Biotechnology and has over twenty five years’ experience in the sector including the commercialisation of innovative technologies and forming, funding, development and exiting of technology start-ups. Peter provides Apex Molecular with valuable strategic guidance and commercial support.